Yousif Capital Management LLC Purchases 10,813 Shares of Teleflex Incorporated (NYSE:TFX)

Yousif Capital Management LLC boosted its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 149.8% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 18,031 shares of the medical technology company's stock after buying an additional 10,813 shares during the period. Yousif Capital Management LLC's holdings in Teleflex were worth $2,492,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of TFX. CANADA LIFE ASSURANCE Co lifted its holdings in Teleflex by 0.4% in the fourth quarter. CANADA LIFE ASSURANCE Co now owns 20,320 shares of the medical technology company's stock valued at $3,614,000 after buying an additional 74 shares during the period. MassMutual Private Wealth & Trust FSB lifted its stake in shares of Teleflex by 103.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock valued at $27,000 after purchasing an additional 100 shares during the period. True Wealth Design LLC grew its stake in Teleflex by 62.3% during the fourth quarter. True Wealth Design LLC now owns 271 shares of the medical technology company's stock worth $48,000 after purchasing an additional 104 shares during the period. Isthmus Partners LLC increased its holdings in Teleflex by 7.3% in the fourth quarter. Isthmus Partners LLC now owns 1,535 shares of the medical technology company's stock worth $273,000 after purchasing an additional 105 shares in the last quarter. Finally, QRG Capital Management Inc. increased its stake in shares of Teleflex by 5.8% in the 4th quarter. QRG Capital Management Inc. now owns 2,178 shares of the medical technology company's stock valued at $388,000 after acquiring an additional 119 shares in the last quarter. 95.62% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have recently commented on TFX. Bank of America downgraded Teleflex from a "neutral" rating to an "underperform" rating and decreased their price objective for the company from $235.00 to $140.00 in a report on Tuesday, March 4th. Royal Bank of Canada lowered their price objective on shares of Teleflex from $150.00 to $145.00 and set a "sector perform" rating on the stock in a report on Friday, May 2nd. Wells Fargo & Company dropped their price target on shares of Teleflex from $146.00 to $137.00 and set an "equal weight" rating on the stock in a research report on Friday, May 2nd. Truist Financial cut their target price on Teleflex from $140.00 to $137.00 and set a "hold" rating on the stock in a research report on Monday, May 5th. Finally, Wall Street Zen lowered Teleflex from a "buy" rating to a "hold" rating in a research report on Friday, February 28th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $164.63.

Teleflex Stock Performance

Shares of NYSE:TFX traded up $1.32 during mid-day trading on Monday, reaching $121.25. The company had a trading volume of 18,821 shares, compared to its average volume of 626,023. Teleflex Incorporated has a one year low of $118.70 and a one year high of $249.91. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The company's 50-day moving average price is $126.73 and its 200-day moving average price is $152.12. The firm has a market cap of $5.36 billion, a price-to-earnings ratio of 24.10, a PEG ratio of 1.73 and a beta of 1.10.

Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The medical technology company reported $2.91 EPS for the quarter, topping the consensus estimate of $2.88 by $0.03. The company had revenue of $700.67 million during the quarter, compared to the consensus estimate of $699.37 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Teleflex's revenue for the quarter was down 5.0% on a year-over-year basis. During the same period last year, the firm earned $3.21 EPS. As a group, equities research analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, June 16th. Shareholders of record on Tuesday, May 20th will be issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 1.12%. The ex-dividend date of this dividend is Tuesday, May 20th. Teleflex's payout ratio is 42.90%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.